News & Publications – Page 4 – Clinical Pharmaceutical Sciences

2025

August 1, 2025

Interplay of cultural beliefs, psychological disposition, and social milieu during childhood on development of substance use disorder by early adulthood

Kirisci L, Reynolds M, Vanyukov M, Fabian T, Tarter R.

Exp Clin Psychopharmacol. 2025 Aug;33(4):407-415. DOI: 10.1037/pha0000776. Epub 2025 May 5. PMID: 40323844.

July 12, 2025

Towards an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communities

Klein CJ, Gong L, Caudle KE, Naik H, Empey PE, Hoffman JM, Scherer S, Iwuchukwu OF, Gregornik D, Monte AA, Swen JJ, Scott SA, Whirl-Carrillo M, Klein TE.

Genet Med. 2025 Oct;27(10):101529. DOI: 10.1016/j.gim.2025.101529. PubMed PMID: 40662343.

July 1, 2025

Topical gel/microsphere eyedrop for combined delivery of brimonidine and timolol: A comparative study with traditional eye drops in rabbits

Fan X, Harding PA, Ziaei P, Caudhry AB, West 3rd RE, Nolin TD, DiLeo MV.

Transl Vis Sci Technol. 2025 Jul 1;14(7):15. DOI: 10.1167/tvst.14.7.15. PMID: 40693711.

July 1, 2025

CYP2D6 phenotypes and emergency department visits among patients receiving opioid treatment

Nahid NA, McDonough CW, Wei Y-J, Gong Y, Empey PE, Haddad A, Fillingim RB, Johnson JA.

JAMA Netw Open. 2025 Jul 1;8(7):e2523543. DOI: 10.1001/jamanetworkopen.2025.23543. PMID: 40720122.

June 27, 2025

Buprenorphine and norbuprenorphine concentrations associated with clinical withdrawal during pregnancy

Caritis SN, Krans EE, Venkataramanan R.

Drug Alcohol Depend. 2025 Sep 1:274:112771. DOI: 10.1016/j.drugalcdep.2025.112771. PMID: 40633180.

June 25, 2025

Pharmacokinetic analysis of morphine-3-glucuronide after acute morphine intravenous bolus administration to rats with traumatic brain injury

Birabaharan J, Henchir J, Svirsky S, Nolin TD, Empey PE, Carlson SW.

J Pharmacol Exp Ther. 2025 Aug;392(8):103645. DOI: 10.1016/j.jpet.2025.103645. PMID: 40729783.

June 18, 2025

Anticoagulation optimization through a specialized center for atrial fibrillation

Coons JC, Singla V, White E, Byers E, Dueweke E, Mulukutla S, Solano F, Jain SK.

Am J Med Qual. 2025 Nov-Dec 01;40(6):261-265. DOI: 10.1097/JMQ.0000000000000261. PMID: 40528318.

June 17, 2025

Using machine learning to predict medication therapy problems among patients with chronic kidney disease

Alghwiri AA, Weltman MR, Lavenburg LMU, Han Z, Nolin TD, Chen Y-F, Yabes JG, Jhamb M.

Am J Nephrol. 2025 Jun 17:1-11. DOI: 10.1159/000546540. PMID: 40527301.

June 6, 2025

Population health management impact on healthcare utilization and costs in CKD: Post hoc analysis of the Kidney Coordinated HeAlth Management Partnership Trial

Suh K, Kogan J, Chan C, Paley C, Yang J, Weltman MR, Good C, Rollman BL, Nolin TD, Yabes JG, Jhamb M.

Clin J Am Soc Nephrol. 2025 Jun 6;20(8):1063-1071. DOI: 10.2215/CJN.0000000754. PMID: 40478756.

June 4, 2025

Progress in pharmacogenomics implementation in the united states: barrier erosion and remaining challenges

Smith DM, Douglas MP, Aquilante CL, Deverka PA, Devine B, Dunnenberger HM, Empey PE, Hertz DL, Monte AA, Moyer AM, Patel JN, Pratt VM, Saulsberry L, Scott SA, Voora D, Woodahl EL, Whirl-Carrillo 25 M, Oni-Orisan A, Pharmacogenomics Global Research Network (PGRN) Publications Committee

Clin Pharmacol Ther. 2025 Oct;118(4):778-789. DOI: 10.1002/cpt.3736. PMID: 40468601.

All Publications